1. Paradoxical Response to Tuberculosis Treatment in a Patient Receiving Tumor Necrosis Factor-Alpha Antagonist 
Caroline Moureau, Lucie Pothen, MD, Dunja Wilmes, MD, Jean Cyr Yombi, MD, Emmanuel Coche, MD, PhD, Philippe Hainaut, MD, PhD 
The American Journal of Medicine 
Volume 125, Issue 6, Pages e9-e10 (June 2012)
DOI: /j.amjmed
Copyright © 2012 Elsevier Inc. Terms and Conditions

2. Figure 1
Enhanced chest computed tomography at the beginning of treatment revealed small lymphadenopathy in the right retroclavicular and right paratracheal areas. The central portion of a lymph node in the right retroclavicular area showed low attenuation suggesting necrosis (arrow).
The American Journal of Medicine  , e9-e10DOI: ( /j.amjmed )
Copyright © 2012 Elsevier Inc. Terms and Conditions

3. Figure 2
Enhanced chest computed tomography after 2 months of treatment demonstrated a major increase in the size of lymphadenopathy with obvious necrosis (arrows) in both locations.
The American Journal of Medicine  , e9-e10DOI: ( /j.amjmed )
Copyright © 2012 Elsevier Inc. Terms and Conditions